FDA device listing

ADVIA Centaur XPT Cytokeratin Fragment 21-1 MCM (CYFRA MCM) - Siemens,ADVIA Centaur XPT Tumor Marker Quality Controls…

FDA device listing 1508983017 · Fujirebio Diagnostics, Inc.

Key facts

Proprietary names ADVIA Centaur XPT Cytokeratin Fragment 21-1 MCM (CYFRA MCM) - Siemens,ADVIA Centaur XPT Tumor Marker Quality Controls (TMQC) - Siemens,Alinity i CYFRA 21-1 Controls,Alinity i CYFRA 21-1 Controls (China),Alinity i CYFRA 21-1 Controls (ROW),Alinity i Methotrexate Controls (China),Alinity i Methotrexate Controls (ROW),Alinity i Methotrexate Extended Range Controls (China),Alinity i Methotrexate…
Owner/operator Fujirebio Diagnostics, Inc.
Owner/operator number 10022860
Product codes JJX
Device names JJX - Single (Specified) Analyte Controls (Assayed And Unassayed)
Device class Class I
Classification regulations (21 CFR) 862.1660
Review panels Clinical Chemistry
Registered establishments Fujirebio Diagnostics, Inc., Fujirebio Europe N.V., Fujirebio Inc.
Establishment registrations 1643621, 2521625, 9615837, 3002895169
FEI numbers 1643621, 2521625, 3002608770, 3002895169
Establishment operations Contract Manufacturer, Manufacturer
Registration valid through 2026

At a glance

  • 1–9 Registered establishments listing this device
  • None listed Premarket submission listed

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA device listings

Establishments that make or process devices for the U.S. market must list each device with the FDA. A listing records the device's proprietary names, product codes and premarket submission, and every registered establishment that handles it.

Source: U.S. Food and Drug Administration (FDA), Establishment Registration and Device Listing database

Browse all FDA device listings